Executive Director, Investor Relations @ (November 2021 - February 2024)
Sr Director, Investor Relations @ (September 2021 - November 2021)
Director, Investor Relations @ (February 2019 - September 2021)
Associate Director, Investor Relations @ (June 2017 - February 2019)
Sr Manager, Investor Relations @ (January 2015 - June 2017)
Manager, Investor Relations @ (June 2014 - January 2015)
Product Manager, US Tecfidera Marketing @ (July 2012 - June 2014)
Consultant @ (August 2010 - March 2013)
Co-Founder and Business Development and Marketing Manager @ (February 2006 - July 2010)
Summer Intern, Global Neurology Marketing @ (May 2011 - August 2011)
Analyst @ (August 2006 - May 2007)
Intern @ Shire HGT (January 2005 - January 2006)
Intern @ Innovasep (January 2000 - January 2002)
Michael Hencke Education
Harvard Business School
MBA
2010-2012
Massachusetts Institute of Technology
S.B. (Chemical Engineering, minors in Chemistry and Biomedical Engineering)
2002-2006
Michael Hencke Skills
Customer Service
Public Relations
Investor Relations
Business Strategy
Strategy
PowerPoint
Microsoft Office
Medical Devices
Technology
Microsoft Excel
Michael Hencke Summary
Michael Hencke, based in Wellesley, MA, US, is currently a Vice President, Corporate Affairs at Dyne Therapeutics. Michael Hencke brings experience from previous roles at Kendall Investor Relations, LLC and Biogen. Michael Hencke holds a 2010 - 2012 MBA @ Harvard Business School. With a robust skill set that includes Customer Service, Public Relations, Investor Relations, Business Strategy, Strategy and more. Michael Hencke has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Michael Hencke?
Find contact details for 700 million professionals.